David G. Bostwick
#90,807
Most Influential Person Now
David G. Bostwick's AcademicInfluence.com Rankings
David G. Bostwickbiology Degrees
Biology
#4137
World Rank
#6215
Historical Rank
Pathology
#43
World Rank
#97
Historical Rank
Download Badge
Biology
Why Is David G. Bostwick Influential?
(Suggest an Edit or Addition)David G. Bostwick's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder (1998) (1501)
- Effect of dutasteride on the risk of prostate cancer. (2010) (1063)
- Classification of renal cell carcinoma (1997) (843)
- Human prostate cancer risk factors (2004) (628)
- Intraductal dysplasia: a premalignant lesion of the prostate. (1986) (570)
- PATTERNS OF PROGRESSION IN PROSTATE CANCER (1986) (561)
- Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma (2000) (546)
- Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer (1987) (517)
- Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. (1998) (502)
- Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. (1997) (481)
- cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. (1996) (462)
- Urologic Surgical Pathology (1997) (434)
- Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma (1998) (412)
- The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. (2008) (395)
- A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. (1997) (391)
- Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. (2006) (390)
- Artificial neural networks improve the accuracy of cancer survival prediction (1997) (380)
- Risk of prostate carcinoma death in patients with lymph node metastasis (2001) (350)
- Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. (1995) (324)
- Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group (2012) (312)
- Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. (2001) (303)
- Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. (1994) (298)
- Keratin immunoreactivity in the benign and neoplastic human prostate. (1985) (294)
- Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. (1999) (291)
- Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. (2004) (285)
- Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. (1995) (283)
- Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. (1996) (283)
- Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. (1998) (275)
- Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. (1997) (274)
- Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer (2000) (272)
- Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. (2020) (270)
- Overexpression of the EphA2 tyrosine kinase in prostate cancer (1999) (263)
- Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. (1998) (259)
- Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. (1994) (252)
- Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. (1999) (252)
- Architectural patterns of high-grade prostatic intraepithelial neoplasia. (1993) (244)
- Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. (1995) (243)
- Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines (2000) (241)
- Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. (1997) (240)
- High-grade prostatic intraepithelial neoplasia (2004) (226)
- The association of benign prostatic hyperplasia and cancer of the prostate (1992) (220)
- Molecular biology of prostatic intraepithelial neoplasia (1996) (220)
- Lipoxygenase‐5 is overexpressed in prostate adenocarcinoma (2001) (216)
- High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer (1995) (215)
- Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. (1993) (214)
- Correlation of margin status and extraprostatic extension with progression of prostate carcinoma (1999) (213)
- Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. (1997) (210)
- Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. (1999) (205)
- Expression of early growth response genes in human prostate cancer. (1998) (204)
- Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. (1985) (204)
- Independent origin of multiple foci of prostatic intraepithelial neoplasia (1998) (202)
- The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. (1997) (198)
- Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance (1994) (198)
- Ovarian epithelial tumors of borderline malignancy: A clinical and pathologic study of 109 cases (1986) (198)
- Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. (2009) (196)
- Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. (2000) (193)
- Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen (1998) (188)
- Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. (1996) (186)
- The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. (1995) (186)
- The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. (1995) (183)
- Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. (1997) (182)
- Grading prostate cancer. (1994) (178)
- Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. (2012) (175)
- The radial distance of extraprostatic extension of prostate carcinoma (1999) (173)
- Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. (2006) (172)
- Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. (1996) (168)
- High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers. (2000) (165)
- Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. (1996) (164)
- Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia (1996) (164)
- Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases (2000) (163)
- Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. (1996) (161)
- Temperature-correlated histo pathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia (1996) (158)
- Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. (1994) (157)
- Prostatic adenocarcinoma with endometrioid features: Clinical, pathologic, and ultrastructural findings (1985) (155)
- Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. (2007) (152)
- A review of clinical and pathological prostatitis syndromes. (1997) (151)
- Conservative Treatment of Borderline Ovarian Tumors (1985) (149)
- Overexpression of the wild type p73 gene in human bladder cancer (1999) (149)
- The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. (1997) (149)
- Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. (1995) (147)
- Predicting the survival of bladder carcinoma patients treated with radical cystectomy (2000) (147)
- Survival of patients with carcinoma in situ of the urinary bladder (1999) (145)
- Staging of early prostate cancer: a proposed tumor volume-based prognostic index. (1993) (145)
- Radiation injury of the normal and neoplastic prostate (1982) (144)
- Human acid ceramidase is overexpressed but not mutated in prostate cancer (2000) (140)
- Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. (1998) (138)
- Microvessel density in renal cell carcinoma: lack of prognostic significance. (1995) (137)
- Natural history of urothelial dysplasia of the bladder. (1999) (137)
- Inflammatory Pseudotumor and Sarcoma of Urinary Bladder: Differential Diagnosis and Outcome in Thirty-Eight Spindle Cell Neoplasms (2001) (137)
- Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. (1998) (137)
- Interobserver Variability Between Expert Urologic Pathologists for Extraprostatic Extension and Surgical Margin Status in Radical Prostatectomy Specimens (2008) (135)
- Prostatic intraepithelial neoplasia (2000) (134)
- Predicting cancer progression in patients with stage T1 bladder carcinoma. (1999) (130)
- Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. (1995) (130)
- Staging of prostate cancer. (1994) (130)
- Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. (2000) (128)
- Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. (1997) (127)
- Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer (1999) (127)
- Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. (1997) (126)
- Neuroendocrine cells in human prostate over‐express the anti‐apoptosis protein survivin (2001) (126)
- High-Grade Prostatic Intraepithelial Neoplasia and Atypical Small Acinar Proliferation: Predictive Value for Cancer in Current Practice (2005) (123)
- Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. (1999) (122)
- Malignant lymphoma involving the prostate (1998) (122)
- Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. (1999) (121)
- Carcinosarcoma of the prostate. Report of 21 cases (1995) (120)
- A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma (1997) (118)
- Prostatic intraepithelial neoplasia (PIN): Current concepts (1992) (117)
- Cancer volume of lymph node metastasis predicts progression in prostate cancer. (1998) (117)
- Solitary plasmacytoma of bone: treatment, progression, and survival. (1987) (116)
- Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. (2005) (115)
- Precursors of prostate cancer (2012) (113)
- Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. (2007) (113)
- Accuracy of frozen section diagnosis in surgical pathology: review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. (1995) (113)
- Epidemiology of High-Grade Prostatic Intraepithelial Neoplasia (2000) (112)
- PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. (1993) (112)
- Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. (1997) (112)
- College of American Pathologists Conference XXXV: Solid tumor prognostic factors - Which, how and so what? Summary document and recommendations for implementation (2000) (111)
- Prostatic intraepithelial neoplasia (PIN). (1989) (111)
- Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer (2012) (110)
- Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. (2003) (110)
- The definition and preoperative prediction of clinically insignificant prostate cancer. (1996) (109)
- Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? (1998) (109)
- Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. (2007) (109)
- In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. (2000) (109)
- Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. (1999) (105)
- Workgroup I: Rodent models of prostate cancer (1998) (105)
- Malignant lymphomas involving the prostate a study of 13 cases (1985) (105)
- Expression of p27kip1 in prostatic adenocarcinoma. (1998) (104)
- Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. (1997) (104)
- Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. (1999) (104)
- Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup. (1999) (104)
- Effects of ammonium acetate and sodium cholate on N-methyl-N'-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. (1988) (103)
- Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma (2000) (102)
- Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. (1996) (102)
- Molecular profiling of clinical tissues specimens: feasibility and applications. (2000) (102)
- Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. (1998) (102)
- Flat intraepithelial lesions of the urinary bladder (2000) (101)
- Understanding the pathological features of focality, grade and tumour volume of early‐stage prostate cancer as a foundation for parenchyma‐sparing prostate cancer therapies: active surveillance and focal targeted therapy (2011) (101)
- Molecular profiling of clinical tissue specimens: feasibility and applications. (2000) (100)
- Decrease of prostatic intraepithelialneoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy (1994) (100)
- Atypical Basal Cell Hyperplasia of the Prostate: Immunophenotypic Profile and Proposed Classification of Basal Cell Proliferations (1993) (99)
- Papillary urothelial neoplasms of low malignant potential (1999) (99)
- Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. (2000) (98)
- Phyllodes tumor of the prostate: long-term followup study of 23 cases. (2004) (97)
- Leiomyosarcoma of the prostate. Report of 23 cases (1995) (97)
- The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. (2000) (96)
- TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. (2014) (96)
- Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. (2002) (96)
- Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. (2001) (96)
- Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. (2004) (94)
- Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. (2007) (94)
- Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression (2002) (94)
- Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. (2009) (93)
- Parenchymal brain metastases from adenocarcinoma of prostate. (1986) (92)
- Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. (1996) (92)
- Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. (1994) (92)
- Adenoid Cystic/Basal Cell Carcinoma of the Prostate: Clinicopathologic Findings in 19 Cases (2003) (91)
- Postatrophic Hyperplasia of the Prostate: A Histologic Mimic of Prostatic Adenocarcinoma (1995) (91)
- Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. (1997) (91)
- Pathologic classification of prostate carcinoma (1998) (90)
- Does prostatic ductal adenocarcinoma exist? (1999) (89)
- Dysplasia and cancer complicating strictures in ulcerative colitis (1990) (89)
- Minimal or No Cancer in Radical Prostatectomy Specimens: Report of 13 Cases of the “Vanishing Cancer Phenomenon” (1995) (88)
- A molecular cytogenetic analysis of 7q31 in prostate cancer. (1997) (87)
- Paraganglioma of the urinary bladder (2000) (87)
- Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. (1998) (86)
- The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. (2011) (86)
- Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. (2007) (85)
- Neuroendocrine Differentiation in Prostatic Intraepithelial Neoplasia and Adenocarcinoma (1994) (84)
- Loss of imprinting and allele switching of p73 in renal cell carcinoma (1998) (84)
- Prostatic intraepithelial neoplasia is a risk factor for cancer. (1999) (83)
- The effects of the dual 5α‐reductase inhibitor dutasteride on localized prostate cancer—results from a 4‐month pre‐radical prostatectomy study (2006) (83)
- Androgen deprivation as a strategy for prostate cancer chemoprevention. (1997) (83)
- Microvessel density in prostate cancer: prognostic and therapeutic utility. (1998) (83)
- Diagnosis and grading of bladder cancer and associated lesions. (1999) (83)
- Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists (2016) (82)
- Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States. (2005) (81)
- Platelet‐derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasia (1996) (81)
- Hemangioma of the urinary bladder (1999) (80)
- Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies (2003) (80)
- Staging prostate cancer--1997: current methods and limitations. (1997) (79)
- High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers. (2000) (79)
- The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. (1995) (79)
- Staging of prostate cancer (2012) (79)
- Cellular and Molecular Pathology of Prostate Cancer Precursors (2000) (78)
- Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. (1996) (78)
- Allelic imbalance in gastric cancer: An affected site on chromosome arm 3p (1995) (78)
- The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostate. (2005) (77)
- Genetic and Chromosomal Alterations in Prostatic Intraepithelial Neoplasia and Carcinoma Detected by Fluorescence in situ Hybridization (1999) (77)
- Does finasteride alter the pathology of the prostate and cancer grading? (2004) (77)
- Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. (1998) (77)
- Molecular Genetic Evidence for Different Clonal Origin of Components of Human Renal Angiomyolipomas (2001) (77)
- Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee. (2000) (76)
- Molecular genetics and histopathologic features of adult distal nephron tumors. (2002) (76)
- Natural history of early bladder cancer (1992) (76)
- Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. (1996) (75)
- Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists (2020) (75)
- Diagnosis of prostate cancer in needle biopsies after radiation therapy. (1999) (75)
- High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. (1997) (73)
- Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). (2006) (73)
- Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. (1994) (73)
- Neurofibroma of the urinary bladder (1999) (72)
- Intraepithelial and stromal lymphocytes in the normal human prostate (2003) (72)
- Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma. (1996) (72)
- Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. (2001) (71)
- Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. (1994) (70)
- Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration. (1996) (68)
- Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma (2000) (68)
- Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy (1998) (68)
- Tumor size predicts the survival of patients with pathologic stage t2 bladder carcinoma (1999) (67)
- Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. (1997) (67)
- Amphetamine induced cerebral vasculitis. (1981) (67)
- Atypical nephrogenic metaplasia of the urinary tract (2000) (66)
- Evaluating radical prostatectomy specimens: Therapeutic and prognostic importance (2005) (66)
- ‘Vanishing’ prostate cancer in radical prostatectomy specimens: incidence and long‐term follow‐up in 38 cases (2004) (65)
- Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice. (2008) (65)
- Urothelial papillary (exophytic) neoplasms (2002) (64)
- Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. (1996) (64)
- Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. (2004) (63)
- Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. (1996) (63)
- Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. (1996) (63)
- Expression of opioid peptides in tumors. (1987) (63)
- Microvascular invasion in prostate cancer correlates with pathologic stage. (1995) (63)
- Angiosarcoma of the head and neck: Review of 11 cases (1986) (63)
- Diagnosis and classification of renal cell carcinoma. (1999) (63)
- Androgen receptor expression in prostatic intraepithelial neoplasia and cancer. (1999) (63)
- Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer † (2002) (63)
- Paneth Cell‐like Change of the Prostate Gland: A Histological, Immunohistochemical, and Electron Microscopic Study (1991) (62)
- Accuracy of frozen-section diagnosis of mammographically directed breast biopsies. Results of 1,490 consecutive cases. (1995) (62)
- Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. (2005) (62)
- Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. (1996) (62)
- Transitional cell carcinoma of the prostate (1998) (61)
- Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. (2005) (61)
- An enhanced prognostic system for clinically localized carcinoma of the prostate (1997) (60)
- Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue. (2004) (59)
- Atypical Adenomatous Hyperplasia of the Prostate: Relationship with Carcinoma in 217 Whole‐mount Radical Prostatectomies (1995) (59)
- Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. (2007) (59)
- Mesoblastic Nephroma of Adulthood Report of Three Cases (1993) (59)
- THE EFFECTS OF 5α-REDUCTASE INHIBITORS ON THE NATURAL HISTORY, DETECTION AND GRADING OF PROSTATE CANCER: CURRENT STATE OF KNOWLEDGE (2005) (58)
- Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. (1997) (58)
- 10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer. (2000) (58)
- Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer (1997) (58)
- Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis (2010) (57)
- Overdiagnosis of prostatic adenocarcinoma. (1999) (57)
- Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop. (1998) (56)
- p53 Protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy (1999) (56)
- Prostatic intraepithelial neoplasia occurs spontaneously in the canine prostate. (1997) (56)
- Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma. (1999) (56)
- Urothelial papilloma of the bladder (1999) (56)
- Evaluating prostate needle biopsy: Therapeutic and prognostic importance (1997) (56)
- Allelic imbalance in the clonal evolution of prostate carcinoma (1999) (55)
- Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression (2005) (54)
- Extranodal Extension in Lymph Node–Positive Prostate Cancer (2000) (54)
- Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. (1999) (54)
- The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. (1994) (53)
- The pathology of early prostate cancer (1989) (53)
- Squamous papilloma of the urinary tract is unrelated to condyloma acuminata (2000) (52)
- Needle core length in sextant biopsy influences prostate cancer detection rate. (2002) (52)
- High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer (1998) (52)
- Premalignant lesions of the prostate. (1988) (51)
- Comparison of renal ablation with cryotherapy, dry radiofrequency, and saline augmented radiofrequency in a porcine model. (2001) (51)
- Dedifferentiation in the metastatic progression of prostate carcinoma (1999) (50)
- Workgroup 1: Origins of prostate cancer (1996) (50)
- Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. (1999) (50)
- Prostatic intraepithelial neoplasia and the origins of prostatic carcinoma. (1995) (49)
- Establishment of the formalin-free surgical pathology laboratory. Utility of an alcohol-based fixative. (1994) (49)
- Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. (2008) (48)
- Cardiac metastases from soft-tissue sarcomas. (1986) (48)
- Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis (2003) (48)
- The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration. (1995) (48)
- Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies (2005) (48)
- p53 Alteration in regional lymph node metastases from prostate carcinoma (1999) (48)
- Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense γ‐enolase expression (1999) (48)
- Prostate cancer microvessels: a novel method for three‐dimensional reconstruction and analysis (1998) (47)
- Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. (1996) (47)
- Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding. (1995) (46)
- Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies (2010) (45)
- Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 93 cases (2004) (44)
- Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. (1994) (44)
- Epithelioid hemangioendothelioma (histiocytoid hemangioma) of the palate (1987) (44)
- Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. (1996) (44)
- Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. (1995) (44)
- Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia. (1996) (44)
- Diagnosis of Prostatic Intraepithelial Neoplasia: Prostate Working Group 1 Consensus Report (2000) (43)
- Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. (1997) (43)
- Atypical small acinar proliferation in the prostate: clinical significance in 2006. (2009) (43)
- Large-cell calcifying Sertoli cell tumor of the testis: appearance at sonography. (1994) (43)
- Recommendations for the reporting of resected prostate carcinomas (1997) (42)
- Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia. (2001) (41)
- Gastrin-releasing peptide-related peptides in a human malignant lung carcinoid tumor. (1983) (41)
- Mutation and expression analysis of the p73 gene in prostate cancer (1999) (40)
- Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. (2014) (40)
- prostatic xanthoma: a mimic of prostatic adenocarcinoma. (1994) (40)
- Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. (1999) (40)
- Glutathione S-transferase: differential expression of α, μ, and π isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma (2007) (40)
- Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. (1999) (39)
- Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. (1994) (39)
- Comparing the age at prostate cancer diagnosis in humans and dogs. (1996) (39)
- Prostatic intraepithelial neoplasia: Animal models 2000 (2000) (39)
- Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. (2004) (38)
- Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors. (1995) (38)
- Pleomorphic giant cell carcinoma of the prostate. (2005) (38)
- College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. (2000) (38)
- Prostate biopsy and optimization of cancer yield. (2006) (38)
- Diagnosis of prostatic carcinoma after therapy. (2009) (37)
- Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias. (2003) (37)
- Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. (1996) (37)
- Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. (2000) (37)
- Contemporary pathology of prostate cancer. (2003) (37)
- Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications. (2003) (36)
- Cystosarcoma phyllodes of the seminal vesicle (1993) (36)
- Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. (2009) (36)
- Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. (1999) (36)
- Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials (1996) (35)
- Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. (1984) (35)
- Gadolinium-enhanced MRI in the evaluation of minimally invasive treatments of the prostate: correlation with histopathologic findings. (2003) (35)
- Prediction of individual patient outcome in cancer (2001) (34)
- Mucin expression in atypical adenomatous hyperplasia of the prostate. (1995) (34)
- Reversibility of Prostatic Intraepithelial Neoplasia: Implications for Chemoprevention (1999) (33)
- Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma. (1997) (33)
- Utility of Pathology Imagebase for standardisation of prostate cancer grading (2018) (33)
- Absence of p16/MTS1 gene mutations in human prostate cancer. (1996) (33)
- Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors. (1984) (33)
- Gastrin releasing peptide in human neuroendocrine tumours (1985) (32)
- Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy (2010) (32)
- Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma. (1998) (31)
- Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation‐induced haemorrhagic cystitis (2004) (31)
- Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate (2007) (30)
- Over‐diagnosis of high‐grade prostatic intraepithelial neoplasia: a prospective study of 251 cases (2007) (30)
- Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. (2007) (30)
- Practical clinical application of predictive factors in prostate cancer. A review with an emphasis on quantitative methods in tissue specimens. (1998) (30)
- Bladder Pathology: Cheng/Bladder Pathology (2012) (30)
- Steam heat with an EDTA buffer and protease digestion optimizes immunohistochemical expression of basal cell-specific antikeratin 34betaE12 to discriminate cancer in prostatic epithelium. (1999) (29)
- Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. (2009) (28)
- Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions. (1987) (28)
- Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer. (2000) (28)
- Transurethral microwave thermal therapy: Pathologic findings in the canine prostate (1995) (28)
- Growth-hormone-releasing factor immunoreactivity in human endocrine tumors. (1984) (28)
- Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literature. (2004) (28)
- The pathology of incidental carcinoma. (1995) (28)
- Urinary β2-Microglobulin Is a Good Indicator of Proximal Tubule Injury: A Correlative Study with Renal Biopsies (2014) (27)
- Panel III: Report of the committee on staging and pathology (1992) (27)
- Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma. (2003) (27)
- Prostatic adenocarcinoma with glomeruloid features. (1998) (26)
- Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization. (1996) (26)
- World Health Organization and International Society of Urological Pathology classification and Two‐number grading system of bladder tumors (2000) (26)
- Gastric adenocarcinoma after gastric lymphoma (1987) (26)
- Mesonephric Remnants of the Prostate: Incidence and Histologic Spectrum (2003) (26)
- Prostatic Intraepithelial Neoplasia: The Preinvasive Stage of Prostate Cancer: Overview of the Prostate Committee Report (2000) (25)
- Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer. (1999) (25)
- Spermatic cord and testicular adnexae (2008) (25)
- Transurethral hot-water balloon thermoablation for benign prostatic hyperplasia: patient tolerance and pathologic findings. (2000) (25)
- Biopsy Pathology of the Prostate (1998) (25)
- The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. (1997) (25)
- Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens. (2000) (25)
- Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. (2003) (24)
- Antimicrobial resistance genes and modelling of treatment failure in bacterial vaginosis: clinical study of 289 symptomatic women. (2016) (24)
- Ultrastructure of prostatic intraepithelial neoplasia (1997) (24)
- The pathologist as optimist: cancer grade deflation in prostatic needle biopsies. (1998) (24)
- Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes (2007) (23)
- Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. (1999) (23)
- The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma (2004) (23)
- Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. (2019) (22)
- Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary? (2000) (22)
- Minimal criteria for the diagnosis of prostate cancer on needle biopsy. (1997) (22)
- Prostate cancer detected by uPM3: radical prostatectomy findings (2006) (22)
- Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men. (1999) (22)
- Does subdivision of the “atypical” urine cytology increase predictive accuracy for urothelial carcinoma? (2014) (22)
- Predictors of cancer progression in T1a prostate adenocarcinoma. (1999) (22)
- Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis. (2001) (22)
- Significance of the TMPRSS2:ERG gene fusion in prostate cancer (2013) (22)
- Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas. (1999) (21)
- c-erbB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role. (1994) (21)
- Papillary adenocarcinoma of the male urethra: Case report and review of the literature (1984) (21)
- Predictors of cancer progression in T1a prostate adenocarcinoma (1999) (21)
- Prostatic leiomyoma with atypia: follow-up study of 10 cases. (2008) (21)
- Overdiagnosis of bladder carcinoma. (2008) (20)
- Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence (2019) (20)
- Prostatic Response to Supranutritional Selenium Supplementation: Comparison of the Target Tissue Potency of Selenomethionine vs. Selenium-Yeast on Markers of Prostatic Homeostasis (2012) (20)
- Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides. (2014) (20)
- Conference summary (1997) (20)
- Immunohistochemical changes in prostate cancer after androgen deprivation therapy. (2000) (20)
- Basal cell-specific anti-keratin antibody 34betaE12: optimizing its use in distinguishing benign prostate and cancer. (1999) (20)
- Ferromagnetic self-regulating reheatable thermal rod implants for in situ tissue ablation. (2002) (20)
- Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy. (1999) (20)
- Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. (1999) (20)
- Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading (2020) (19)
- Prostatic intraepithelial neoplasia and well differentiated adenocarcinoma maintain an intact basement membrane. (1995) (19)
- Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy. (2015) (19)
- Prostate Adenocarcinoma After Androgen Deprivation Therapy: A Comparative Study of Morphology, Morphometry, Immunohistochemistry, and DNA Ploidy (1996) (19)
- Atypical sclerosing adenosis of the prostate: a rare mimic of adenocarcinoma (2010) (19)
- Progression of T1 bladder tumors (1999) (19)
- Subepithelial pelvic hematoma of the kidney clinically mimicking cancer: report of six cases and review of the literature. (1999) (18)
- Laparoscopic partial nephrectomy with a novel electrosurgical snare in a porcine model. (2002) (18)
- Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? (1999) (18)
- Flutamide in Men with Prostatic Intraepithelial Neoplasia: A Randomized, Placebo-Controlled Chemoprevention Trial (2006) (18)
- Isolation and characterization of epithelial cells from bovine pancreatic duct (1978) (18)
- 98: The Relationship Between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the Reduce Trial (2007) (18)
- Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present. (2000) (18)
- Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey. (2000) (18)
- Current and proposed biologic markers in prostate cancer (1992) (17)
- Atypical Adenomatous Hyperplasia (Adenosis) of the Prostate: DNA Ploidy Analysis and Immunophenotype (2005) (17)
- CASE REPORT: Graft-Versus-Host-Like Colitis and Malignant Thymoma (2002) (17)
- ASAP is a valid diagnosis (1999) (17)
- Prostate cancer outcome: epidemiology and biostatistics. (2005) (17)
- Origins of prostate cancer. (1996) (16)
- High grade prostatic intraepithelial neoplasia with squamous differentiation (2006) (16)
- Isolated granulomatous gastritis in an adolescent (1989) (16)
- Essentials of Anatomic Pathology (2002) (16)
- Karyometry of secretory cell nuclei in high‐grade PIN lesions * (2001) (16)
- The Gleason Score: A Significant Biologic Manifestation of Prostate Cancer Aggressiveness On Biopsy (2001) (16)
- FURTHER ANALYSES FROM THE REDUCE PROSTATE CANCER RISK REDUCTION TRIAL (2009) (16)
- Gastrin-releasing peptide immunoreactivity in intestinal carcinoids. (1984) (15)
- Treatment of experimental bladder cancer with hyperthermia and phase transition liposomes containing methotrexate. (1988) (15)
- Atypical spindle cell lesions of the prostate. (1988) (15)
- Prostate biopsy interpretation. Current concepts, 1999. (1999) (15)
- Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. (2000) (15)
- The Art of Casting Nets: Fishing for the Prize of Personalized Cancer Prevention (2007) (15)
- Biopsy misidentification identified by DNA profiling in a large multicenter trial. (2011) (15)
- Prostate-specific antigen as a marker of prostate disease (2000) (15)
- Keratin Protein In Human Prostatic Tissue and Cell Culture (1985) (14)
- Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. (2003) (14)
- Improved filter method for urine sediment detection of urothelial carcinoma by fluorescence in situ hybridization. (2009) (14)
- Prostate needle biopsy quality in reduction by dutasteride of prostate cancer events study: worldwide comparison of improvement with investigator training and centralized laboratory processing. (2010) (14)
- The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. (2005) (14)
- Prostatic adenocarcinoma following androgen deprivation therapy: the new difficulty in histologic interpretation. (1998) (13)
- Neoplasms of the Prostate (2020) (13)
- Diagnosis of hepatic allograft rejection: role of liver biopsy. (1993) (13)
- Neuroendocrine innervation of the hepatic vessels in the rat and in man. (1988) (13)
- Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization (2011) (13)
- Epidemiology and statistical methods in prediction of patient outcome (2005) (12)
- Transurethral enzymatic ablation of the prostate: canine model. (1996) (12)
- Pathology for Urologists (2003) (12)
- Smooth-muscle regeneration after electrosurgical endopyelotomy in a porcine model as confirmed by electron microscopy. (2004) (12)
- Urinary β2-Microglobulin is a Sensitive Indicator for Renal Tubular Injury (2014) (12)
- Adequate histologic sectioning of prostate needle biopsies. (2013) (12)
- Radiofrequency identification specimen tracking in anatomical pathology: pilot study of 1067 consecutive prostate biopsies. (2013) (11)
- ASAP is a valid diagnosis. Atypical small acinar proliferation. (1999) (11)
- Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia (2004) (11)
- Long-term follow-up of untreated stage T1a prostate cancer. (1998) (11)
- Immunolocalization of glycoprotein A-80 in prostatic carcinoma and prostatic intraepithelial neoplasia. (1996) (11)
- APPLES AND ORANGES: COMPARISON OF TREATMENT METHODS FOR PROSTATE CANCER USING BIOCHEMICAL RECURRENCE AS AN ENDPOINT (2012) (10)
- Pathological Findings in TRUS Prostatic Biopsy—Diagnostic, Prognostic and Therapeutic Importance (2002) (10)
- Prostate biopsy 1999: strategies and significance of pathological findings. (1999) (10)
- Precursor of prostate‐specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases (2009) (10)
- Normal Anatomy and Histology (2012) (10)
- Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. (2013) (10)
- Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. (1994) (10)
- Non-neoplastic diseases of the prostate (2008) (10)
- Conference summary: First international workshop on animal models of prostate cancer (1998) (9)
- Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (2005) (9)
- Prediction of Extraprostatic Extension of Prostate Cancer Based on Needle Biopsy Findings: Perineural Invasion Lacks Significance on Multivariate Analysis (1998) (9)
- Humoral hypercalcemia complicating adenosquamous carcinoma of the proximal colon (2005) (9)
- Adult urinary bladder rhabdomyosarcoma. (2008) (9)
- Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma. (1997) (9)
- Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies (2014) (9)
- Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011. (2013) (9)
- American Cancer Society's complete guide to prostate cancer (2005) (9)
- Robust 3-D Reconstruction and Analysis of Microstructures from Serial Histologic Sections, with Emphasis on Microvessels in Prostate Cancer (1996) (9)
- Sarcomas and related proliferative lesions of specialized prostatic stroma. (1999) (9)
- Homeostatic housecleaning effect of selenium: evidence that noncytotoxic oxidant-induced damage sensitizes prostate cancer cells to organic selenium-triggered apoptosis. (2013) (8)
- Inflammatory and Infectious Conditions (2012) (8)
- Prostate-Specific Antigen and Pathology of the Prostate (1995) (8)
- Stability of the glycoprotein A-80 in prostatic carcinoma subsequent to androgen deprivation therapy. (1997) (8)
- Microvascular invasion of the seminal vesicles in adenocarcinoma of the prostate (1996) (7)
- Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatment. (2003) (7)
- Atypical Small Acinar Proliferation of the Prostate: 16 Years’ Experience (2014) (7)
- CYCLOSPORIN-INDUCED REMISSION IN SEVERE COLITIS UNRESPONSIVE TO CORTICOSTEROID THERAPY (1987) (7)
- Postatrophic Hyperplasia of the Prostate (1996) (7)
- Alterations in glycoconjugate expression following malignant transformation of human oropharyngeal squamous mucosa (1989) (7)
- Atypical Small Acinar Proliferation in the Prostate (2008) (7)
- Does polyomavirus infection interfere with bladder cancer fluorescence in situ hybridization? (2014) (7)
- Anatomy of the prostatic urethra. (1984) (7)
- Chapter 14 – Immunohistology of the Prostate, Bladder, Testis and Kidney (2006) (7)
- Modeling and analysis of Gleason score 8-10 prostate cancers in the REDUCE study. (2014) (6)
- Comprar Urologic Surgical Pathology Expert Consult online + print | Liang Cheng | 9780323019705 | Mosby (2008) (6)
- Molecular Profiling of Clinical Tissue Specimens (2000) (6)
- Characterization of prostate cancer in needle biopsy by cathepsin B, cell proliferation and DNA ploidy. (2010) (6)
- 690: Toremifene for the Prevention of Prostate Cancer Among 514 Men with High-Grade Prostatic Intraepithelial Neoplasia (PIN): Results of a Double-Blind, Placebo-Controlled Phase IIB Trial (2005) (6)
- ProstAsure Index in the detection of prostate cancer. (1998) (6)
- Histologic Variants of Urothelial Carcinoma (2012) (6)
- Clinically unsuspected and undetected (clinical stage t0) prostate cancer diagnosed on random needle biopsy. (1999) (6)
- College of American Pathologists Conference XXXV: Solid Tumor Prognostic Factors—Which, How and So What? (2009) (6)
- Clinical utility of prostatic intraepithelial neoplasia. (1995) (6)
- The radial distance of extraprostatic extension of prostatic adenocarcinoma: Implications for prostate brachytherapy (1998) (6)
- Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?: Editorial comment (2004) (6)
- Spermatic Cord and Testicular Adnexa (2020) (6)
- Target populations and strategies for chemoprevention trials of prostate cancer. (1994) (5)
- Next generation sequencing reveals disparate population frequencies among cytochrome P450 genes: clinical pharmacogenomics of the CYP2 family (2016) (5)
- Low‐grade prostate cancer should still be labelled cancer (2022) (5)
- 97: Lack of Relationship between Clinical Prostatitis and Prostate Inflammation: Baseline Data From the Reduce Trial (2006) (5)
- Prostatic stromal proliferations: a review. (2020) (5)
- Selenium Form-Dependent Anti-Carcinogenesis: Preferential Elimination of Oxidant-Damaged Prostate Cancer Cell Populations by Methylseleninic Acid is Not Shared by Selenite (2015) (5)
- Recent Advances in the Quantitative Morphological Evaluation of Prostate Neoplasia (2000) (5)
- 176 EXAMINATION OF THE RELATIONSHIP BETWEEN PROSTATE INFLAMMATION, LOWER URINARY TRACT SYMPTOMS AND CLINICAL PROSTATITIS-LIKE SYMPTOMS: BASELINE DATA FROM THE REDUCE TRIAL (2007) (5)
- Quality assurance in the laboratory diagnosis of prostate cancer (1995) (5)
- Essentials of anatomic pathology: Fourth edition (2016) (5)
- Lymphoid and Hematopoietic Tumors (2012) (5)
- Tissue‐based Biomarkers (2012) (4)
- High-grade prostatic intraepithelial neoplasia. (2004) (4)
- Bladder Cancer: General Features (2012) (4)
- Tumors of the Kidney, Bladder and Related Urinary Structures, 4th ed. (2005) (4)
- Grading of Bladder Cancer (2012) (4)
- Original Articles: Kidney Cancer (1995) (4)
- HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL SMALL ACINAR PROLIFERATION ARE SIGNIFICANT CANCER RISK FACTORS: FOLLOW-UP STUDY OF 1,476 CASES (2009) (4)
- Optimizing prostate specimen handling for diagnosis and prognosis. (2014) (3)
- Mixed Carcinoid-Adenocarcinoma of the Prostate With Spindle Cell Carcinoid: The Spectrum of Neuroendocrine Differentiation in Prostatic Neoplasia (1996) (3)
- THE CELL CYCLE INHIBITORS p21WAF1 AND p27KIP1 ARE ASSOCIATED WITH SURVIVAL IN PATIENTS TREATED BY SALVAGE PROSTATECTOMY AFTER IRRIDIATION (1999) (3)
- 7-Urine Cytology (2019) (3)
- Participation of functionally active plasma cells in acute rejection and response to therapy in renal allografts. (2014) (3)
- A symposium on the surgical pathology of the prostate. (1990) (3)
- Neoplasms of the Urinary Bladder (2020) (3)
- Molecular Pathology of Bladder Cancer (2012) (3)
- Androgen deprivation therapy for precancerous lesions of the prostate. (2008) (3)
- Immunohistochemical Biomarkers of Prostatic Carcinoma (2014) (3)
- Soft Tissue Tumors (2012) (3)
- Quality Assurance in Prostate Biopsy Sampling, Processing, and Reporting: A New Pathologic Paradigm for Prostate Cancer Diagnosis (2013) (3)
- Prostate cancer grading, time to go back to the future (2020) (3)
- 141 UTILIZATION TRENDS AND POSITIVE BIOPSY RATES FOR PROSTATE BIOPSIES IN THE UNITED STATES, 2005-2011 (2013) (3)
- Urothelial Carcinoma In Situ (2012) (3)
- Inauguration of the Prostate Cancer Focal Therapy Debate (2007) (3)
- Demonstrability of the glycoprotein A-80 in postradiation prostatic carcinoma. (1999) (2)
- Premalignant and early malignant lesions of the prostate (1992) (2)
- Prostate pathology case study seminar (2005) (2)
- Expression of the Macrophage-Associated Antigen CD68/KP1 by Tumor Cells of Sarcomatoid Renal Cell Carcinoma (1999) (2)
- CHAPTER 32 – Prostate (2009) (2)
- 691: Effects of Testosterone Administration on Prostate Tissues in Men with Adam Syndrome (2006) (2)
- PCA3: A urine-based genetic assay for detection of prostate cancer in men with elevated PSA. (2010) (2)
- Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. (2000) (2)
- A Molecular Cytogenetic Analysis of 7 q 31 in Prostate Cancer 1 (2006) (2)
- Prostate biopsy interpretation : Current concepts, 1999 : Uropathology (1999) (2)
- Stage pT1 Urothelial Carcinoma (2012) (2)
- Atypical Small Acinar Proliferation of the Prostate Gland (1998) (2)
- Prostate biopsies using both gray scale and 3D color flow power doppler ultrasound (3DCFPDU). (2015) (2)
- Identification of patients with low‐risk for aneuploidy: Comparative discriminatory models using linear and machine‐learning classifiers in prostate cancer (2007) (2)
- Three-dimensional visualization and analysis of microvessels in prostate cancer (1995) (2)
- Urothelial Carcinoma Following Augmentation Cystoplasty (2012) (2)
- Selenium, apoptosis, and DNA damage: Defining the optimal selenium dose for human prostate cancer prevention. (2006) (2)
- Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia (1993) (2)
- What is the significance of race to prostate carcinoma? (1999) (2)
- Seminal Vesicles (2020) (2)
- Diagnosis and classification of renal cell carcinoma : Uropathology (1999) (1)
- Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization (2010) (1)
- Erratum: Frequent loss of heterozygosity at 7q31.1 is associated with tumor aggressiveness and progression (Cancer Research (September 15, 1995) 55 (4114-4119)) (1996) (1)
- Flat Urothelial Lesions with Atypia and Urothelial Dysplasia (2012) (1)
- Florid Basal Cell Hyperplasia and Other Benign Mimics of Prostate Cancer (2014) (1)
- DETECTION OF CHROMOSOMAL ANOMALIES IN CHROMOPHOBE RENAL CELL CARCINOMA USING FLUORESCENCE IN SITU HYBRIDIZATION (2009) (1)
- Pathologic findings after prostatic cryoablation (2007) (1)
- Comprar Urologic Surgical Pathology: Expert Consult - Online and Print, 3e | Cheng, L. | 9781455743278 | Saunders (2013) (1)
- 2048 ERG GENE TRANSLOCATION PREDICTS PROGRESSION OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA TO PROSTATE CANCER (2013) (1)
- Prostate cancer masquerading as a zygomatic posttraumatic mass. (1997) (1)
- ATYPICAL SMALL ACINAR PROLIFERATIONS. AUTHORS' REPLY (1999) (1)
- Current and proposed biologic markers in prostate cancer: 1994. (1994) (1)
- Squamous Cell Carcinoma and Other Squamous Lesions (2012) (1)
- Detection of early prostate cancer: serendipitous or systematic? (1998) (1)
- Abstract 6540: Regression of metastatic cancer and abscopal effects followingin situvaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series (2020) (1)
- Handling and Reporting of Bladder Specimens (2012) (1)
- LONG-TERM FOLLOW-UP OF PATIENTS WITH CARCINOMA IN SITU OF THE URINARY BLADDER (1999) (1)
- Atypical Small Acinar Proliferations (1999) (1)
- Adenocarcinoma and Its Putative Precursors and Variants (2012) (1)
- 284: Monitoring Superficial Bladder Cancer (BC) with the Immunocyt Fluorescent Cytology Test (2004) (1)
- Prostatitis and Urethritis (1999) (1)
- Prostate Cancer: Optimal Tissue Processing for Diagnosis and Prognosis (2014) (1)
- Deletion of 9p21 in urine specimens collected from patients with a history of hematuria and bladder cancer. (2016) (1)
- Phyllodes Tumor of the Prostate: Current Concepts and Update on Classification of Prostatic Soft Tissue Tumors (2007) (1)
- CLINICAL T1c AND T2 PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY: OUTCOME ACCORDING TO PRE-OPERATIVE PSA AND CLINICAL GRADE IN THE PSA ERA (1999) (1)
- 137Superficial bladder cancer risk category and the impact of review pathology (2005) (1)
- Utilization and cancer detection by U.S. prostate biopsies (2005-2011). (2013) (1)
- Conserved Genetic Findings in Metastatic Bladder Cancer (2009) (1)
- Urothelial Metaplasia and Hyperplasia (2012) (1)
- The Effects of theDual 5 a-Reductase Inhibitor Dutasteride onLocalized ProstateCancer Results Froma 4-Month Pre-Radical ProstatectomyStudy (2006) (0)
- ANALYSIS OF RISK FACTORS FOR PROGRESSION IN PATHOLOGICALLY CONFINED PROSTATE CANCERS RETROPUBIC PROSTATECTOMY (1996) (0)
- PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) IS A MARKER OF SIGNIFICANT PROSTATE CANCER (1999) (0)
- INFLUENCE OF PERINEPHRIC FAT INVASION ON SURVIVAL, TUMOR RECURRENCE AND METASTASIS 10 YEARS AFTER RADICAL NEPHRECTOMY (1999) (0)
- Pathology of Renal Pelvis, Ureter, and Urethra (2012) (0)
- 344 PREDICTORS OF SEXUAL DYSFUNCTION IN OLDER MEN: BASELINE DATA FROM THE REDUCE TRIAL (2007) (0)
- 24. Treatment Effects (2012) (0)
- Efficacy of ferumoxytol as a lymphatic contrast agent in prostate cancer. (2018) (0)
- Xanthoma of the prostate: another source of confusion with prostatic cancer (1995) (0)
- Predicting C ancer P rogression i n P atients W ith S tage T 1 Bladder C arcinoma (1999) (0)
- Morphological, growth, and chromosomal changes in bovine pancreatic duct epithelial cells exposed toN-methyl-N′-nitro-N-nitrosoguanidine (1980) (0)
- Select Problems in Prostate Specimen Diagnosis (1996) (0)
- Prostate Pathology, 2014: Current Concepts and Controversies (2014) (0)
- SOME EFFECTSOF PHOSPHORUSON THE DEVELOPMENT, THE B VITAMINCONTENT,AND THE INORGANIC COMPOSITIONOF OATS (1951) (0)
- Congenital Disorders and Pediatric Neoplasms (2012) (0)
- 1669: Is High-Grade Prostatic Intraepithelial Neoplasia (PIN) More Frequent than Previously Estimated? (2005) (0)
- 1088: Separation of Chromophobe Renal Cell Carcinoma from Oncocytoma and Clear Cell Carcinoma: An Optimal Immunohistochemical Panel for Differential Diagnosis (2006) (0)
- 14 UNDERSTANDING THE PATHOLOGICAL FEATURES OF PROSTATE CANCER AS A FOUNDATION FOR FOCAL TARGETED BT (2012) (0)
- 2136 APPLICATION OF FOUR COLOR FLUORESCENCE IN SITU HYBRIDIZATION IDENTIFIES GENOMIC DELETIONS OF THE PTEN GENE IN 384 OF 2115 (18.2%) DIAGNOSTIC PROSTATE CANCER-POSITIVE NEEDLE CORES (2013) (0)
- SUBSTAGING OF T1 BLADDER CARCINOMA: 1.5 mm IS THE OPTIMAL CUTOFF FOR THE DEPTH OF INVASION MEASURED BY MICROMETER (1999) (0)
- Other Rare Tumors (2012) (0)
- Detection of chromosomal anomalies in uterine endometrial carcinoma using fluorescence in situ hybridization (UteroFISH). (2009) (0)
- Polyps and Other Nonneoplastic Benign Conditions (2012) (0)
- Nonneoplastic Diseases of the Prostate (2020) (0)
- Preface to Second Edition of Urologie Surgical Pathology (2008) (0)
- Chapter 23 – Prostate Cancer on the Internet: Review 2002 (2003) (0)
- 30. Urinary Cytology (2012) (0)
- More is not always better: using the dog model to identify what dose of selenium provides the best protection against prostate cancer (2008) (0)
- High-Grade Prostatic Intraepithelial Neoplasia and Intraductal Carcinoma With Intraluminal Small Cell Features (2014) (0)
- Problems in Prostate and Bladder Pathology (2008) (0)
- Advances in Brief Expression of Cyclooxygenase-2 ( COX-2 ) in Human Invasive Transitional Cell Carcinoma ( TCC ) of the Urinary Bladder 1 (1999) (0)
- Pathological Implications of Prostate Biopsy (2013) (0)
- 23. Secondary Tumors (2012) (0)
- 387 THE INFLUENCE OF UNSCHEDULED BIOPSIES ON PROSTATE CANCER DETECTION IN THE REDUCE (REDUCTION OF DUTASTERIDE IN CANCER EVENTS) TRIAL (2009) (0)
- Laser evaporation of the prostate: preliminary findings in canines (1996) (0)
- Defining Clinically Insignificant Prostate Cancer-Reply (1996) (0)
- Renal Neoplasms: An Ever-changing Landscape (2005) (0)
- Premaliganant and early malignant lesions of the bladder (1992) (0)
- Pathology of the Urachus (2012) (0)
- Effect of radiotherapy on prostate histopathology and assessment of residual cancer (2005) (0)
- OPTIMAL OUTCOME PREDICTION AFTER RADICAL PROSTATECTOMY (1999) (0)
- Tumors of the Kidney (2011) (0)
- Molecular Determinants of Tumor Recurrence (2012) (0)
- Worldwide comparison of prostate needle biopsy quality in the reduction by dutasteride of prostate cancer events (REDUCE) study: Improvement with investigator training. (2009) (0)
- PCA3: A urine-based genetic assay for detection of prostate cancer in men with elevated PSA (2009) (0)
- GRADING OF UROTHELIAL CARCINOMA: A NEW PROPOSAL (1999) (0)
- LONG-TERM FOLLOW-UP OF UNTREATED STAGE TA WHO GRADE 1 UROTHELIAL CARCINOMA (1999) (0)
- SOME EFFECTS OF PHOSPHORUS ON THE DEVELOPMENT, THE B VITAMIN CONTENT, AND THE INORGANIC COMPOSITION OF OATS. (1951) (0)
- Pathologic Basis for Focal Therapy: Understanding Cancer Grade, Volume, and Spatial Location (2013) (0)
- Preface to the Fourth Edition (2020) (0)
- Urine Cytology (2020) (0)
- NEW PROPOSAL FOR SUBCLASSIFICATION OF STAGE T2 BLADDER CANCER (1999) (0)
- Prostate Cancer Grading: Contemporary Practice and Controversies (2014) (0)
- ISOLATION AND CHARACTERIZATION OF EPITHELIAL CELLS (2016) (0)
- Vol. 35, 1999 (1999) (0)
- Conference summary (0)
- Erratum: Correlation of pretherapy prostate cancer characteristics with histologic finding from pelvic lymphadenectomy specimens (International Journal of Radiation Oncology Biology (1996) 34 (33-39)) (1996) (0)
- Evaluation of Hematuria and Urinalysis (2012) (0)
- Abstract/Case Study Review Committee for the College of American Pathologists 2017 Annual Meeting (CAP17). (2017) (0)
- RE: MALIGNANT EXTRAGASTROINTESTINAL STROMAL TUMOR OF BLADDER (2004) (0)
- TOPOGRAPHIC RELATIONSHIP OF HIGH-GRADE PIN WITH ATROPHY AND ADENOCARCINOMA (2009) (0)
- Subject Index Vol. 35, 1999 (1999) (0)
- Chapter 4 – High-grade Prostatic Intraepithelial Neoplasia (2003) (0)
- 1707: Precursor of PSA (PRO-PSA) Expression in Prostatic Intraepithelial Neoplasia and Adenocarcinoma: A Study of 90 Cases (2007) (0)
- A Molecular Cytogenetic Analysis of 7q31 in Prostate (2006) (0)
- Urine‐based Biomarkers (2012) (0)
- In Reply: Re (1996) (0)
- Bladder Tumors with Inverted Growth (2012) (0)
- No Cancer in a Radical Prostatectomy Specimen: Report of a Case of the Vanishing Cancer Phenomenon (1996) (0)
- Long-Term Results of Optimized Focal Therapy for Prostate Cancer : Average 10-Year Follow-Up in 70 Patients (2014) (0)
- Frequent Loss of Heterozygosity at 7q31.1 Is Associated with Tumor Aggressiveness and Progression (1996) (0)
- 5. Benign Epithelial Tumors (2012) (0)
- Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer (2023) (0)
- 805 EFFECTS OF PROSTATITIS ON SERUM PSA AND URINARY PCA3 GENE SCORE (2010) (0)
- Original Articles PROSTATIC INTRAEPITHELIAL NEOPLASM IS A RISK FACTOR FOR ADENOCARCINOMA: PREDICTIVE ACCURACY IN NEEDLE BIOPSIES (1996) (0)
- Bombesin, IsPresent inHuman Neuroendocrine LungTumors (1984) (0)
- Esophagus and Stomach (2002) (0)
- Correlation between quality of prostate biopsy and pathological diagnosis in the REDUCE study after 2 and 4 years of treatment with dutasteride. (2010) (0)
- The predictive value of HGPIN and ASAP for the subsequent diagnosis of prostate cancer in the Reduction by Dutasteride of Cancer Events (REDUCE) study. (2010) (0)
- The Effect of Calcium on the B Vitamin and Inorganic Content of Oats (2015) (0)
- Words of wisdom: Re: Biopsy misidentification identified by DNA profiling in a large multicenter trial. (2011) (0)
- 11. Staging of Bladder Cancer (2012) (0)
- The Effects of theDual 5a -Reductase Inhibitor Dutasteride onLocalized ProstateCancer Results (2006) (0)
- Microvessel Density in Needle Biopsies May Help Predict Stage (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David G. Bostwick?
David G. Bostwick is affiliated with the following schools:
